Imprimer

Sorafenib (BAY 43-9006)

Marques : Apollo Scientific
Ratings: Ecrire un avis

Total Evaluation: 0
Moyenne des Notes : 0.0 sur 5

Synonyme(s): 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide, Sorafenib, N-[4-Chloro-3-(trifluoromethyl)phenyl]-N′-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea, 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide

BISN0134-500MG BISN0134-1G BISN0134-5G
APOSBISN0134-500MGEA 50.9 EUR
APOSBISN0134-500MG APOSBISN0134-1G APOSBISN0134-5G
Sorafenib (BAY 43-9006)
Sorafenib (BAY 43-9006)

Sorafenib is a multikinase inhibitor of Raf-1 B-Raf and VEGFR-2 with IC50 of 6 nM 22 nM and 90 nM in cell-free assays respectively.

Formule: C₂₁H₁₆ClF₃N₄O₃
Point de fusion: 197 °C
Densité: 1,46 g/cm³ (25 °C)
Température de stockage: Réfrigérateur
Numéro MDL: MFCD06411450
Numéro CAS: 284461-73-0
UN: 3077
ADR: 9+EHS,III

Commander maintenant


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR